Patent · US Active

Substance that specifically recognizes PD-1

US7858746B2 · kind B2 · utility

50Cited by
2References
2Claims
0Family size

Assignees

Inventors

Key dates

Filing dateMar 28, 2008
Grant dateDec 28, 2010
Priority date
Expiry dateApr 24, 2029

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compounds that can recognize selectively both PD-1 protein and a membrane protein co-existing with PD-1 on a cell membrane, and can transmit a suppressive signal of PD-1. The compounds are useful for medical treatment and/or prevention of diseases caused by immune abnormality.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.